People ages 40–49 with high-risk conditions who are registered on the national COVID-19 vaccination platform will now start receiving the Pfizer-BioNTech vaccine, the Lebanese Vaccine Executive Committee announced

Now is not the time to stop reading!

Get unlimited access to L'Orient Today for $1 only.

Already have an account? Log in

Create a free account